D132G (p.Asp132Gly) variant of CALM2 (Calmodulin-2)
D132G (p.Asp132Gly) in CALM2 (Calmodulin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Long QT syndrome 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.57 / 1. The record also includes published literature and structural context.
D132G (p.Asp132Gly) variant details
- p.Asp132Gly
- rs1687164164
- ClinGen CA346719049
- ClinVar RCV002241435
- Ensembl rs1687164164
- Pathogenic
- Long QT syndrome 1
- Missense
- Variant Prioritization Score for Impact Estimate 0.566
- AlphaMissense 0.98
- MetaLR 0.53
- MetaSVM 0.14
- SIFT 0.00
- MutPred 0.76
- ClinVar: Pathogenic (Long QT syndrome 1)
- EBI: Pathogenic (in LQT15)
- UniProt: Pathogenic (in LQT15)
- Structural context available
- Cited in: Long QT Syndrome Overview. (PMID 20301308)
- Cited in: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this… (PMID 21810866)